Peer Review History

Original SubmissionAugust 24, 2021
Decision Letter - Anneloes van Baar, Editor

PONE-D-21-27377Internalizing Symptoms and Family Functioning Predict Adolescent Depressive Symptoms during COVID-19: a Longitudinal Study in a Community SamplePLOS ONE

Dear Dr. Vacaru,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Anneloes van Baar, PhD

Academic Editor

PLOS ONE

Journal requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Funding Section of your manuscript:

“The BIBO study was supported by a Netherlands Organization for Scientific Research VIDI grant (575-25-009, to CdW), VICI grant (016.185.038, to CdW), VENI grant (016.195.197, to RB), an Early Career Award of the Royal Netherlands Academy of Arts and Sciences (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The BIBO study was supported by a Netherlands Organization for Scientific Research VIDI grant (575-25-009, to CdW), VICI grant (016.185.038, to CdW), VENI grant (016.195.197, to RB), an Early Career Award of the Royal Netherlands Academy of Arts and Sciences (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

The study presents important information as it is able to relate pre-existing information regarding functioning and development of the adolescents to new information gathered during the first lockdown in The Netherlands. Both risk as well as protective factors could be used, specifically regarding overall family functioning and social connectedness.

Some clarification is needed in the manuscript.

In the Methods it is stated that data were collected in two waves: please explain when exactly.

In the Results the following is stated:

In 2019, internalizing and externalizing symptoms were 10 and 16% above the clinical cut-off,

191 respectively, whereas during the lockdown, depressive symptoms were 24% above the cut-off

192 (Table 1).

Please add the % of internalizing and externalizing symptoms above the clinical cut-off in 2020, as well as the % that showed depressive symptoms above clinical cut-off in 2019 – to allow more precise comparisons.

In the Discussion is stated:

Although we only assessed internalizing symptoms, and not depressive symptoms, prior

to the lockdown….

Why didn’t you study the specific relationship between prior depressive symptoms and depressive symptoms during the lockdown? Please explain either in the Discussion or clarify your research questions in this regard in the Introduction.

You also state:

It could be that adolescents from high educated, wealthy and low risk families may be even less prepared to face a challenging crisis than adolescents who have previously experienced hardship. How does this idea relate to your sample? Please explain.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Reviewer’s comments

Thank you for the opportunity to review this paper. This is an interesting study, with clearly defined aim, generally well-written, nice longitudinal and multi-informant design, and with interesting results. I am positive about this study being published. Below, please find my comments, which I believe might improve the manuscript.

Introduction:

1. I think the first paragraph is too long. Could it be split in two more homogeneous paragraphs? Or maybe just cut shorter?

2. Line 63: I would say that life events are not “entered”, but experienced.

3. Lines 75-77: the aim can be written a bit more clearly: will you be looking at changes in symptoms pre- to during the first lockdown, or to moderation by pre-existing symptoms? The two previous sentences (lines 72-74) imply testing mean level changes, as they offer contrasting extant evidence for increase or decrease in symptoms. Please clarify the aim.

4. Lines 78-94: I think this paragraph is a bit confusing, as ideas regarding parenting and parent-adolescent relationship quality are intertwined and likely used interchangeably with family systems ideas. I think these two (parenting/parent-adolescent relationship quality and family functioning) are quite distinct concepts. Indeed, in my view family systems theories actually argue for this exact topic: how the system functions as a whole is not the same as how individuals behave (parenting) or how sub-systems within the system (e.g., the parent-adolescent dyad) interact. Please clarify.

5. Related to the above: If your family functioning measure has separate dimensions taping onto family as a system *and* parenting or p-a relationships more specifically, then it would be interesting to see what works best as a buffer: is it the system as a whole, or the parenting more specifically that might buffer during crises like the COVID-19?

6. Lines 90-94: please consider reporting contrasting or clarifying evidence for the potential effects (or absence thereof) of family functioning on adolescent mental health, e.g. Mastrotheodoros et al., 2020 https://doi.org/10.1007/s10964-019-01094-z

7. Lines 116-118: why would you hypothesize that adolescents with higher pre-existing externalizing would show higher internalizing? This comes a bit as a surprise, given the preceding introduction. A bit more clarity here would be welcome. Consider taking into account literature on the general psychopathology (p) factor for the possible interrelations between internalizing and externalizing.

Method:

8. Line 127: I get confused by the mean age reported here, compared to the one reported on line 124. Please clarify.

9. Lines 163-164: it looks like the citation (nr. 36) is wrong? I understand that this is a scale developed recently, but the reference is from 1997?

Results:

10. Lines 190-191: maybe good to remind the reader that those percentages come from different scales?

11. Lines 197-198: girls have higher scores, but the r correlations are negative. This is slightly confusing, not only because of the sign (a “higher” is indicated by a negative sign), but also because of the test statistic. Why r and not t-test? Maybe I am missing something here.

Discussion:

12. Lines 246-248: maybe good to remind the reader that different measures were applied pre- and during the pandemic.

13. Line 267: “across the lifespan” is a bit far-stretched, as there were only data from ages 13-14 in this study.

14. Lines 277-285: I think the evidence from the study suggested above (Mastrotheodoros et al., 2020) is also important here. In that study we found no evidence that family functioning has within-person effects on adolescent psychological symptoms, neither was there evidence for child mental health effects on family functioning. It might be that family functioning and adolescent mental health are only related on the between-person level. Given the results of that study, it would be better to avoid using causal language (line 278: “alleviate”), and keep the interpretation of your results on the between-person level.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Stefanos Mastrotheodoros

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Prof. Anneloes van Baar

Editor

PLOSONE

17th January 2022

Dear Prof. van Baar,

We thank you for the opportunity to resubmit a revised version of our manuscript “Internalizing Symptoms and Family Functioning Predict Adolescent Depressive Symptoms during COVID-19: a Longitudinal Study in a Community Sample” for publication as an original paper in PLOSONE.

We have addressed the comments provided by the reviewer and yourself, and indicated how this was done in a point-by-point fashion below. Based on these constructive and greatly appreciated comments, we improved the clarity of the manuscript with respect to the sample and methodology. Moreover, we now also discuss our findings in line with the interpersonal therapy framework, which highlights the clinical implications of our study. Additionally, we have improved the readability of the paper by adding some linguistic edits.

This work is neither under consideration nor published elsewhere. All authors have approved the final submission of this manuscript and were meaningfully involved in the study.

Overall, we believe that our manuscript has benefitted from the comments and as such is of interest to the readers of PLOSONE. We thank you for your further consideration.

Sincerely,

Stefania V. Vacaru, PhD.,

Roseriet Beijers, PhD.,

Carolina de Weerth, PhD. Prof.

Editor Comments:

1. In the Methods it is stated that data were collected in two waves: please explain when exactly.

We clarified this on p.6 lines 265-266.

2. In the Results the following is stated:

In 2019, internalizing and externalizing symptoms were 10 and 16% above the clinical cut-off,

respectively, whereas during the lockdown, depressive symptoms were 24% above the cut-off

(Table 1). Please add the % of internalizing and externalizing symptoms above the clinical cut-off in 2020, as well as the % that showed depressive symptoms above clinical cut-off in 2019 – to allow more precise comparisons.

In this study, we assessed internalizing/externalizing symptoms prior to the pandemic and depression symptoms during the pandemic. Therefore, the percentages of internalizing/externalizing during the pandemic, and the percentage of depressive symptoms prior to the pandemic are not available.

3. In the Discussion is stated:

Although we only assessed internalizing symptoms, and not depressive symptoms, prior

to the lockdown….

Why didn’t you study the specific relationship between prior depressive symptoms and depressive symptoms during the lockdown? Please explain either in the Discussion or clarify your research questions in this regard in the Introduction.

This study stems from a longitudinal study that started in late pregnancy and followed children across development (BIBO study). The aim of the BIBO study was to examine early predictors of child behavioral development. For this reason, and also because depressive symptoms are less common in early/middle childhood, we examined internalizing and externalizing behavior problems as more broader, overarching constructs of behavior. However, amidst the COVID-19 outbreak, we were worried about deterioration of mental health, especially also as our children had reached early adolescence, an age in which more children start to develop depressive symptoms. That our assessments of behavior were not identical at both waves is now included as a limitation to the Discussion section (pp. 14-15, lines 480-489).

4. You also state:

It could be that adolescents from high educated, wealthy and low risk families may be even less prepared to face a challenging crisis than adolescents who have previously experienced hardship. How does this idea relate to your sample? Please explain.

We added an explanation of this idea to the Discussion (pp. 11-12, lines 396-403). We additionally took out the word ‘wealthy’ to characterize the families as this was an assumption not based on actual financial data.

Reviewer #1:

1. I think the first paragraph is too long. Could it be split in two more homogeneous paragraphs? Or maybe just cut shorter?

We have shortened the first paragraph accordingly (p. 3).

2. Line 63: I would say that life events are not “entered”, but experienced.

We changed the wording as suggested (p. 3, line 59).

3. Lines 75-77: the aim can be written a bit more clearly: will you be looking at changes in symptoms pre- to during the first lockdown, or to moderation by pre-existing symptoms? The two previous sentences (lines 72-74) imply testing mean level changes, as they offer contrasting extant evidence for increase or decrease in symptoms. Please clarify the aim.

We have now clarified the aim (p. 4, lines 82-83).

4. Lines 78-94: I think this paragraph is a bit confusing, as ideas regarding parenting and parent-adolescent relationship quality are intertwined and likely used interchangeably with family systems ideas. I think these two (parenting/parent-adolescent relationship quality and family functioning) are quite distinct concepts. Indeed, in my view family systems theories actually argue for this exact topic: how the system functions as a whole is not the same as how individuals behave (parenting) or how sub-systems within the system (e.g., the parent-adolescent dyad) interact. Please clarify.

We thank the reviewer for pointing this out and have rewritten this paragraph to highlight the distinction between parenting/parent-adolescent relationships aspects, and family functioning (p. 4, lines 87-98).

5. Related to the above: If your family functioning measure has separate dimensions taping onto family as a system *and* parenting or p-a relationships more specifically, then it would be interesting to see what works best as a buffer: is it the system as a whole, or the parenting more specifically that might buffer during crises like the COVID-19?

This is a very interesting question. Given the rationale of the study to look at family functioning in general, and not specific sub-components, in combination with the lack of sufficient power, we did not run additional analyses with the subdomains of family-related aspects. We added these research questions as venues for future research to the discussion section, in combination with the outcomes of our exploratory analyses. The results of these analyses revealed significant main effects of roles, affective responsiveness and affective involvement (p. 13, lines 441-448).

6. Lines 90-94: please consider reporting contrasting or clarifying evidence for the potential effects (or absence thereof) of family functioning on adolescent mental health, e.g. Mastrotheodoros et al., 2020 https://doi.org/10.1007/s10964-019-01094-z

We thank you for pointing us to this work, which we have now added to our introduction (p. 4, lines 95-96).

7. Lines 116-118: why would you hypothesize that adolescents with higher pre-existing externalizing would show higher internalizing? This comes a bit as a surprise, given the preceding introduction. A bit more clarity here would be welcome. Consider taking into account literature on the general psychopathology (p) factor for the possible interrelations between internalizing and externalizing.

We now clarify in our hypothesis that we expect that either internalizing or externalizing symptoms may be linked to higher depressive symptoms during the pandemic, in line with previous reports showing a positive relation between internalizing/externalizing symptoms and depression symptoms (e.g. Vinnakota & Kaur, 2018) (pp. 65-, lines 249-259).

8. Line 127: I get confused by the mean age reported here, compared to the one reported on line 124. Please clarify.

We clarified the mean age and sd for the children at each assessment point (p. 6, lines 265-266).

9. Lines 163-164: it looks like the citation (nr. 36) is wrong? I understand that this is a scale developed recently, but the reference is from 1997?

We corrected this accordingly on p. 8, line 305.

10. Lines 190-191: maybe good to remind the reader that those percentages come from different scales?

We highlighted now that the percentages reported stem from two different scales (p. 9, lines 331-334).

11. Lines 197-198: girls have higher scores, but the r correlations are negative. This is slightly confusing, not only because of the sign (a “higher” is indicated by a negative sign), but also because of the test statistic. Why r and not t-test? Maybe I am missing something here.

We clarified the statistical test used to quantify the relation between the sex variable and internalizing or depressive symptoms and its interpretation in the descriptive analyses section. The sign depends on how sex was coded (0 or 1) and r refers to the correlation coefficient between the sex variable and internalizing or depressive symptoms. For clarity, we also added the t-test values (p. 9, lines 339-342).

12. Lines 246-248: maybe good to remind the reader that different measures were applied pre- and during the pandemic.

We have added that these symptoms were assessed with different instruments (p.11, lines 391-393).

13. Line 267: “across the lifespan” is a bit far-stretched, as there were only data from ages 13-14 in this study.

We deleted this phrasing, p. 12, line 419 and p. 13, line 425.

14. Lines 277-285: I think the evidence from the study suggested above (Mastrotheodoros et al., 2020) is also important here. In that study we found no evidence that family functioning has within-person effects on adolescent psychological symptoms, neither was there evidence for child mental health effects on family functioning. It might be that family functioning and adolescent mental health are only related on the between-person level. Given the results of that study, it would be better to avoid using causal language (line 278: “alleviate”), and keep the interpretation of your results on the between-person level.

We thank you for pointing this out to us. We’ve now rephrased causal language where indicated and throughout the manuscript.

We also add here the funding statement.

Funding: The BIBO study was supported by a Netherlands Organization for Scientific Research VIDI grant (575-25-009, to CdW), VICI grant (016.185.038, to CdW), VENI grant (016.195.197, to RB), an Early Career Award of the Royal Netherlands Academy of Arts and Sciences (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Anneloes van Baar, Editor

Internalizing Symptoms and Family Functioning Predict Adolescent Depressive Symptoms during COVID-19: a Longitudinal Study in a Community Sample

PONE-D-21-27377R1

Dear Dr. Vacaru,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Anneloes van Baar, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you very much for your response to the comments of the reviewer and the editor. You now have clarified and improved your paper. Good luck with your future work.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Anneloes van Baar, Editor

PONE-D-21-27377R1

Internalizing Symptoms and Family Functioning Predict Adolescent Depressive Symptoms during COVID-19: a Longitudinal Study in a Community Sample

Dear Dr. Vacaru:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Anneloes van Baar

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .